Makaleler
21
Tümü (21)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (21)
ESCI (9)
Scopus (21)
TRDizin (11)
9. The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
, cilt.36, sa.4, ss.189-209, 2023 (SCI-Expanded, Scopus)
11. Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
, cilt.183, sa.10, ss.1071-1077, 2022 (SCI-Expanded, Scopus)
12. Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma
Journal of Allergy and Clinical Immunology: In Practice
, cilt.10, sa.7, ss.1935-1936, 2022 (SCI-Expanded, Scopus)
14. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.4, ss.1223-1234, 2022 (SCI-Expanded, Scopus, TRDizin)
15. Classification of asthma severity: Severe/not severe asthma or mild/moderate/severe asthma?
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.70, sa.3, ss.300-301, 2022 (ESCI, Scopus, TRDizin)
19. Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.4, ss.1953-1959, 2021 (SCI-Expanded, Scopus, TRDizin)
20. Blood hyperreosinophilia: A diagnostic challenge
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.3, ss.408-415, 2021 (ESCI, Scopus, TRDizin)
21. Type 2 inflammation in asthma
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.1, ss.114-115, 2021 (ESCI, Scopus, TRDizin)
Metrikler
Yayın (WoS)
21
Yayın (Scopus)
21
Atıf (WoS)
24
H-İndeks (WoS)
3
Atıf (Scopus)
43
H-İndeks (Scopus)
4
Atıf (Scholar)
37
H-İndeks (Scholar)
3
Atıf (TrDizin)
6
H-İndeks (TrDizin)
2
Atıf (Sobiad)
3
H-İndeks (Sobiad)
1
Atıf (Diğer Toplam)
6
Proje
2
